Prevention of Healthcare Associated Infections
Vital Oxide is a Fast and Effective Application to Kill Virus, Bacteria, and Mold that cause Healthcare associated infections.
Some important facts about Vital Oxide:
> Vital Oxide can easily be integrated into Health Care facility disinfection guidelines replacing many existing products that are less effective, and potentially dangerous to the staff. The overall benefit is simply cost and risk reduction.
> Vital Oxide cleans, disinfects and deodorizes hard, nonporous hospital and medical surfaces in one step with no rinsing required.
> Vital Oxide is a one step germicidal disinfectant cleaner and deodorant designed for general cleaning, and disinfecting of hard, nonporous inanimate surfaces. Removes dirt, grime, fungus, mold, food residue, blood and other organic matter commonly found in hospitals and in health care facilities. It also eliminates odours leaving restroom surfaces smelling clean and fresh. Use where odours are a problem. This product may be used to pre-clean or decontaminate critical or semi-critical medical devices prior to sterilization of high level disinfection.
> Vital Oxide will not allow the development of antibiotic-resistant organisms. No need to rotate current disinfectants used.
> Vital Oxide eliminates bad odours and stains caused by blood, urine and feces.
Healthcare associated infections (HAIs) are the number four cause of death in the United States, exceeding the combined mortality of breast cancer, AIDS and traffic accidents. In a 2008 article, the editor of the New England Journal of Medicine estimated that hospital acquired infections add an average of $15,000 to the cost of care which puts a total cost of infections in the U.S. around $40 billion a year. This cost is in addition to the suffering caused by more than 2 million infections a year, over 150,000 deaths and millions of extra days spent in the hospital.
Of equal concern are the evolving antibiotic resistant strains of microorganisms such as Methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter spp, which are making the resulting mortality of a healthcare associated infection greater than ever.
The result has been increased public pressure, and legislative initiatives, holding hospitals accountable for these increased costs. In October of 2008, Medicaid approved a policy to no longer reimburse hospitals for certain preventable errors (including some types of infections) and Medicare is reserving the right to further expand the list. Private insurers are following this lead.
One recent study found that 59% of environmental surfaces were contaminated with MRSA in affected patients’ rooms. Yet a rigorous environmental cleaning intervention can reduce the transmission of MRSA and other multidrug-resistant organisms in hospital intensive care units.
• In a recent study conducted at Nashville General Hospital, Acientobacter spp HAI infections were reduced by 95%. Read The Study Here.